Olanzapine Injection, Powder, Lyophilized, For Solution
Product Images NDC 83854-003

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 83854-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anthea Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Carton Label)

Packaging label for Olanzapine for Injection 10 mg/vial, lyophilized powder for intramuscular use, supplied as a sterile single-dose vial. The label includes the NDC 83854-003-01 and states storage and reconstitution instructions. The product is labeled by Anthea Pharma Private Limited, Hyderabad, India, with a barcode and manufacturing details.*

FDA Label Image

"image Description" (Olanzapine Injection Structure)

Chemical structure of olanzapine, showing its molecular framework with heterocyclic rings containing nitrogen and sulfur atoms, including attached methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.